Safety and immunogenicity of Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children 15 to 24 months of age

This publication has 26 references indexed in Scilit:

• Persistence of antibody and response to booster dose of Haemophilus influenzae type b polysaccharide diphtheria toxoid conjugate vaccine in infants immunized at 9 to 15 months of age
  The Journal of Pediatrics, 1986
• Serum Opsonic Activity for Haemophilus influenzae Type b in Infants Immunized with Polysaccharide-Protein Conjugate Vaccines
  The Journal of Infectious Diseases, 1985
• ANTIBODY LEVELS ACHIEVED IN INFANTS BY COURSE OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE/DIPHTHERIA TOXOID CONJUGATE VACCINE
  The Lancet, 1985
• Safety and immunogenicity of haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of age
  The Journal of Pediatrics, 1985
• Safety and Immunogenicity of Haemophilus influenzae Type B Polysaccharide-Diphtheria Toxoid Conjugate Vaccine in Adults
  The Journal of Infectious Diseases, 1984
• Immunogenicity of Haemophilus influenzae type b polysaccharide—diphtheria toxoid conjugate vaccine in adults
  The Journal of Pediatrics, 1984
• Prevention ofHemophilus influenzaeType B Bacteremic Infections with the Capsular Polysaccharide Vaccine
  New England Journal of Medicine, 1984
• Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.
  The Journal of Experimental Medicine, 1980
• Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants.
  Journal of Clinical Investigation, 1975
• CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS
  The Journal of Experimental Medicine, 1929